BioMed Realty is creating a 482,000-sf life sciences hub in Boston's Seaport District. Previously serving as the corporate headquarters of John Hancock, the building was acquired by BioMed Realty in late 2020. Featuring robust mechanical and electrical systems, the existing structure has attained LEED Platinum sustainable design certification and includes a variety of collaborative meeting areas. The facility will be renovated to provide sophisticated lab and office environments for biomedical companies. Occupancy is expected in the second half of 2022.
With the Seaport acquisition, BioMed Realty's assets will include nearly 5.9 million sf in Boston and Cambridge, with the Boston portfolio almost 100 percent leased. As of December 31, 2020, BioMed owns and operates 11.4 million sf of life science real estate in leading innovation markets in the United States and the United Kingdom, as well as maintaining a development platform with 2.8 million sf of Class A space in active construction.